Michael Halstead Insider Profile
4 Followers
Michael Halstead, Chief Executive Officer at Helus Pharma, holds 168.57K shares in Helus Pharma (Ticker: HELP), holds 0.00 shares in Intra-Cellular Therapies (Ticker: ITCI), holds 15.36K shares in Warner Chilcott (Ticker: WCRX). Most recently, Michael Halstead Bought ― shares of Helus Pharma on Sep 21, 2026 for an estimated value of $1.35M.
Michael Halstead's Trading History
| HELPHelus Pharma | Sep 21, 2026 | Chief Executive Officer | Informative Buy | 1.35M | $1.49M | |
| ITCIIntra-Cellular Therapies | Apr 02, 2025 | ― | Uninformative Sell | 2.81M | $0.00 | |
| WCRXWarner Chilcott | Jun 02, 2011 | ― | Uninformative Buy | ― | ― |
You May Also Like
Michael Halstead insider profile FAQ
What is the percentage of profitable transactions made by Michael Halstead?
The percentage of profitable transactions made by Michael Halstead is 33%.
What is the average return per transaction made by Michael Halstead?
The average return per transaction made by Michael Halstead is 46.80%.
What stocks does Michael Halstead hold?
Michael Halstead holds: HELP, ITCI, WCRX stocks.
What was Michael Halstead’s latest transaction?
Michael Halstead’s latest transaction was an Informative Buy of $1.35M.
What was Michael Halstead's most profitable transaction?
Michael Halstead’s most profitable transaction was an Informative Buy of ITCI stock on November 6, 2014. The return on the trade was 229.90%.
What is Michael Halstead's role in Helus Pharma?
Michael Halstead's role in Helus Pharma is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
